Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.41 USD -0.03 ( 5.77%)
Last update at 2026-11-20T21:00:00Z
VOLUME
17876
Market Cap
6.99M

Momentum Score

…

XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.45
High
52 Week Price Range
1.26
Low
6.40
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

XWELL Inc. is listed on NASDAQ under ticker XWEL; publicly available disclosures about its business operations and segments are limited. Because detailed information is not accessible, major long-term growth drivers cannot be confirmed; investors may find the company's listing and any forthcoming filings or corporate updates of interest for assessing its strategy and prospects.

Key risks include the lack of publicly available operational and financial disclosure, potential early-stage or thinly traded status, and attendant liquidity, governance and execution uncertainties; investors should monitor regulatory filings and management communications.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.44
Dividend Yield
-
Revenue TTM
30.11M
Revenue Per Share
7.21
Gross Profit TTM
12.05M
Debt / Equity
0.85
ROE
-81.34%
Net Debt
2.66M
ROCE
-82.76%
Diluted EPS TTM
-5.92

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -32.57M 3.03M -92.22M -20.68M -35.91M
Minority interest -0.21M 0.46M 1.74M -0.69M -0.46M
Net income -32.63M 3.35M -92.23M -20.53M -37.20M
Selling general administrative 31.17M 24.20M 15.94M 14.32M 16.24M
Gross profit 12.05M 32.43M -3.60M 10.66M 10.64M
Reconciled depreciation 7.27M 4.92M 7.22M 6.12M 9.50M
Ebit -24.55M 5.87M -40.10M -9.78M -14.60M
Ebitda -9.38M 10.78M -16.66M -5.56M -5.10M
Depreciation and amortization 15.17M 4.92M 23.44M 4.22M 9.50M
Operating income -24.55M 5.87M -40.10M -9.78M -34.73M
Other operating expenses 80.49M 68.70M 33.13M 58.30M 65.19M
Interest expense 16.13M 2.38M 1.83M 2.90M 1.83M
Tax provision 0.06M 0.06M 0.01M -0.15M -0.28M
Interest income - 0.04M - - -
Net interest income -0.08M -0.10M -1.83M -2.90M -1.83M
Income tax expense 0.06M 0.14M 0.01M -0.15M -0.28M
Total revenue 55.94M 73.73M 8.38M 48.52M 50.09M
Total operating expenses 36.60M 27.40M 21.15M 20.44M 25.74M
Cost of revenue 43.89M 41.30M 11.98M 37.85M 39.45M
Total other income expense net -8.02M -2.83M -52.12M -10.89M -18.99M
Discontinued operations - - - - -1.11M
Net income from continuing ops -32.63M 2.89M -92.23M -20.53M -35.63M
Net income applicable to common shares -32.84M 3.35M -91.43M -21.22M -37.20M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 38.99M 70.43M 127.27M 103.13M 28.72M
Intangible assets 1.35M 4.01M 3.73M 0.87M 6.78M
Other current assets 0.95M 0.05M 1.09M 0.19M 0.12M
Total liab 18.02M 22.48M 27.33M 22.76M 31.26M
Total stockholder equity 13.00M 39.93M 92.73M 77.81M -6.24M
Other current liab 4.97M 5.72M 6.99M 4.06M 1.81M
Common stock 0.04M 0.83M 1.01M 0.94M 0.49M
Capital stock 0.04M 0.83M 1.01M 0.94M 0.50M
Retained earnings -455.85M -428.11M -395.27M -398.62M -308.14M
Other liab - - - - 3.45M
Good will 1.37M 4.02M - - -
Other assets - - 2.84M -0.00M 1.21M
Cash 8.44M 19.04M 105.51M 89.80M 2.18M
Total current liabilities 9.33M 10.96M 19.83M 13.48M 16.22M
Current deferred revenue 0.86M 0.34M 0.55M 0.89M 3.68M
Net debt 2.66M -4.93M -91.68M -74.42M 13.07M
Short term debt 2.40M 2.59M 6.32M 6.09M 3.67M
Short long term debt - - 3.58M 3.30M -
Short long term debt total 11.09M 14.11M 13.82M 15.38M 15.26M
Other stockholder equity 470.74M 467.74M 487.31M 475.71M 301.68M
Property plant equipment - 11.94M 10.99M 7.20M 16.32M
Total current assets 26.57M 47.33M 108.98M 91.78M 3.93M
Long term investments 0.05M 0.10M 0.72M 1.77M 0.48M
Net tangible assets - 31.89M 89.00M 76.94M -13.03M
Short term investments 14.61M 23.15M - - -
Net receivables 1.67M 2.86M 0.61M 1.14M 0.98M
Long term debt - - - 2.35M 5.76M
Inventory 0.90M 1.16M 1.76M 0.66M 0.65M
Accounts payable 1.10M 2.31M 5.97M 2.44M 7.07M
Accumulated other comprehensive income -1.92M -0.53M -0.31M -0.22M -0.28M
Non currrent assets other 1.79M 3.02M 3.56M 0.79M 0.45M
Non current assets total 12.43M 23.09M 18.29M 11.36M 24.79M
Capital lease obligations 11.09M 14.11M 10.24M 9.73M 9.49M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -34.84M -5.16M -4.35M -2.27M 0.20M
Change to liabilities -4.18M 6.32M -5.17M 3.76M -0.60M
Total cashflows from investing activities -34.84M -5.16M -4.35M -2.27M -1.87M
Net borrowings -3.58M -2.07M 6.24M 2.87M 4.35M
Total cash from financing activities -27.38M 6.35M 117.22M 1.17M 5.64M
Change to operating activities -4.51M -2.46M -3.19M -0.67M -1.89M
Net income -32.63M 2.89M -92.23M -20.53M -35.63M
Change in cash -86.47M 15.76M 87.87M -1.25M -2.96M
Begin period cash flow 106.26M 90.50M 2.63M 3.89M 6.86M
End period cash flow 19.79M 106.26M 90.50M 2.63M 3.89M
Total cash from operating activities -24.19M 15.64M -25.01M -0.11M -6.57M
Issuance of capital stock 0.00M 17.09M 110.62M 0.00M 3.00M
Depreciation 7.27M 4.92M 7.22M 6.12M 9.50M
Dividends paid - -0.01M - - -
Change to inventory 0.59M -1.11M -0.01M 0.14M 0.38M
Change to account receivables -1.83M -0.48M -1.12M -1.12M -1.83M
Sale purchase of stock -23.86M -7.83M - - -
Other cashflows from financing activities -0.03M -0.83M 6.61M 1.29M 5.64M
Change to netincome 11.31M 4.66M 65.36M 8.46M 24.37M
Capital expenditures 6.84M 8.67M 4.35M 2.27M 3.12M
Change in working capital -9.94M 2.71M -8.36M 4.54M -2.12M
Stock based compensation 3.77M 2.86M 1.33M 0.34M 0.92M
Other non cash items 7.33M 0.38M 1.63M 4.81M 1.54M
Free cash flow -31.02M 6.97M -29.36M -2.39M -9.68M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
XWEL
XWELL Inc.
-0.03
5.77%
0.41 - - 0.20 0.31 0.07 0.49
TMO
Thermo Fisher Scientific Inc
-17.51
2.54%
671.24 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation
-0.25
0.11%
220.36 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd
-
-%
23.77 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd
-0.92
3.87%
22.85 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

XWELL Inc.

XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

254 West 31st Street, New York, NY, United States, 10001

212 750 9595

266

Name Title Year Born
Mr. Scott R. Milford Pres, CEO & Director 1964
Mr. Omar A. Haynes Interim Chief Financial Officer 1982
Mr. David Kohel Chief Technology Officer NA
Ms. Cara Soffer Sr. VP & Gen. Counsel NA
Pablo Henderson Chief Marketing Officer NA
Mr. Ezra Ernst Chief Exec. Officer of XpresTest, Inc. NA
Mr. Scott R. Milford President, CEO & Director 1964
Mr. Ezra T. Ernst Executive Vice President 1969
Mr. Omar A. Haynes VP of Treasury & Finance 1983
Ms. Suzanne Scrabis Chief Financial Officer 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…